SO

Shamita Ojha

Active Director Director DIN 07074383
DIN 07074383 First appointment Jun 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Shamita Ojha

Data last updated:

Shamita Ojha is a Director at Amicizia Life Science Private Limited (since 2015). The company operates in Pharma. Amicizia Life Science Private Limited reported revenue of ₹2.29 Cr (FY 2025).

DIN 07074383
Primary Designation Director
Industry Pharma
First Appointment 05 Jun 2015
Oldest Company Age 11 yrs
Largest company Amicizia Life Science Private Limited · ₹2.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jun 20152015₹2.29 Cr (FY 2025)Active

Board colleagues of Shamita Ojha

NameDINCompanyDesignation
Abhijit Ojha07074342Amicizia Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amicizia Life Science Private Limited
Premium access

Shareholding and investment profile for Shamita Ojha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shamita Ojha

Shamita Ojha currently holds 1 directorship: Amicizia Life Science Private Limited (Director, since 05 Jun 2015, revenue ₹2.29 Cr (FY 2025)).

Shamita Ojha was first appointed on 05 Jun 2015 as Director at Amicizia Life Science Private Limited.

The current boards of Shamita Ojha's companies include Abhijit Ojha (Amicizia Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available